Prelude Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Prelude Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$551K	Buy	15,290 +8,328	+120%	+$280K	0.04%	486
2026 Q1	$250K	Sell	6,962 -6,227	-47%	-$161K	0.02%	796
2025 Q4	$262K	Sell	13,189 -15,788	-54%	-$304K	0.02%	863
2025 Q3	$529K	Sell	28,977 -28,449	-50%	-$468K	0.04%	495
2025 Q2	$905K	Sell	57,426 -2,045	-3%	-$26K	0.09%	284
2025 Q1	$754K	Buy	59,471 +37,263	+168%	+$585K	0.06%	380
2024 Q4	$489K	Buy	+22,208	New	+$467K	0.03%	596
2015 Q2	–	Sell	-12,775	Closed	-$307K	–	1742
2015 Q1	$307K	Buy	12,775 +11,475	+883%	+$290K	0.04%	488
2014 Q4	$29K	Buy	+1,300	New	+$33.8K	﹤0.01%	1632
2014 Q1	–	Sell	-1,200	Closed	-$31K	–	1896
2013 Q4	$31K	Buy	+1,200	New	+$33.5K	0.01%	1264
2013 Q3	–	Sell	-3,900	Closed	-$142K	–	1722
2013 Q2	$142K	Buy	+3,900	New	+$140K	0.03%	517

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Prelude Capital Management's CLMT Position: Q2 2026 in Review

Prelude Capital Management increased its Calumet Specialty Products (CLMT) stake by 120% in Q2 2026, buying an estimated $280K and bringing the position to 15,290 shares worth $551K. The position accounts for 0.04% of the portfolio, ranked #486.

Prelude Capital Management first reported a position in CLMT in Q2 2013 and has held it in 11 quarters since. The position peaked at $905K in Q2 2025. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Prelude Capital Management held 15,290 shares of Calumet Specialty Products worth $551K as of Q2 2026.
Prelude Capital Management bought 8,328 Calumet Specialty Products shares in Q2 2026, an estimated $280K.
Calumet Specialty Products made up 0.04% of Prelude Capital Management's portfolio in Q2 2026, its #486 holding.
Prelude Capital Management first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 11 quarters since.
Prelude Capital Management's Calumet Specialty Products position peaked at $905K in Q2 2025.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.